Skip to main content
Top
Published in: Diabetology International 2/2020

01-04-2020 | Neurotomy | Review Article

Spectrum of diabetic neuropathies

Authors: Hideyuki Sasaki, Nobutoshi Kawamura, Peter J. Dyck, P. James B. Dyck, Mikihiro Kihara, Phillip A. Low

Published in: Diabetology International | Issue 2/2020

Login to get access

Abstract

The diabetic state results in neuropathy. The main causative mechanism is hyperglycemia, although microvascular involvement, hypertriglyceridemia, as well as genetic and immune mechanisms may be contributory. There is a growing spectrum of types of diabetic neuropathies that differ based on the type of fibers involved (e.g. myelinated, unmyelinated, autonomic, somatic), distribution of nerves involved, and mechanisms of neuropathy. The most common type is distal sensory neuropathy (DSN), which affects the distal ends of large myelinated fibers, more often sensory than motor, and is often asymptomatic. The next-most common is distal small fiber neuropathy (DSFN), which largely affects the unmyelinated fibers and carries the phenotype of burning feet syndrome. Diabetic autonomic neuropathy (DAN) occurs when widespread involvement of autonomic unmyelinated fibers occurs, and patients can be incapacitated with orthostatic hypotension as well as neurogenic bladder and bowel involvement. Radiculoplexus diabetic neuropathy causes proximal weakness and pain, usually in the lower extremity, and has a combination of immune, inflammatory, and vascular mechanisms. The nerve roots and plexus are involved. These patients present with proximal weakness of a subacute onset, often with severe pain and some autonomic failure. Finally, rapid and sustained reduction of blood glucose can result in treatment-induced diabetic neuropathy (TIND), which largely affects the sensory and autonomic fibers. This occurs if HbA1c is rapidly reduced within 3 months, and the likelihood is proportional to the original A1c and the size of the reduction.
Literature
1.
go back to reference Sinnreich M, Taylor BV, Dyck PJ. Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Neurologist. 2005; 11:63–79.PubMed Sinnreich M, Taylor BV, Dyck PJ. Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Neurologist. 2005; 11:63–79.PubMed
3.
go back to reference Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–24.PubMed Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–24.PubMed
4.
go back to reference Dyck PJ, Karnes JL, O’Brien PC, Litchy WJ, Low PA, Melton LJ III. The Rochester Diabetic Neuropathy study: reassessment of tests and criteria for diagnosis and staged severity. Neurology. 1992;42:1164–70.PubMed Dyck PJ, Karnes JL, O’Brien PC, Litchy WJ, Low PA, Melton LJ III. The Rochester Diabetic Neuropathy study: reassessment of tests and criteria for diagnosis and staged severity. Neurology. 1992;42:1164–70.PubMed
5.
go back to reference Dyck PJ, Davies JL, Litchy WJ, O’Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy study cohort. Neurology. 1997;49:229–39.PubMed Dyck PJ, Davies JL, Litchy WJ, O’Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy study cohort. Neurology. 1997;49:229–39.PubMed
6.
go back to reference Dyck PJ, Davies JL, Clark VM, Litchy WJ, Dyck PJ, Klein CJ, et al. Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care. 2006;29:2282–8.PubMed Dyck PJ, Davies JL, Clark VM, Litchy WJ, Dyck PJ, Klein CJ, et al. Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care. 2006;29:2282–8.PubMed
7.
go back to reference Low PA, Benrud-Larson LM, Sletten DM, Opfer-Gehrking TL, Weigand SD, O’Brien PC, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care. 2004;27:2942–7.PubMed Low PA, Benrud-Larson LM, Sletten DM, Opfer-Gehrking TL, Weigand SD, O’Brien PC, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care. 2004;27:2942–7.PubMed
8.
go back to reference Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ, 3rd, O’Brien PC. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care. 1999;22:1479–86. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ, 3rd, O’Brien PC. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care. 1999;22:1479–86.
9.
go back to reference Anonymous. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986. Anonymous. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.
10.
go back to reference Grisold A, Callaghan BC, Feldman EL. Mediators of diabetic neuropathy: is hyperglycemia the only culprit? Curr Opin Endocrinol Diabetes Obes. 2017;24:103–11.PubMedPubMedCentral Grisold A, Callaghan BC, Feldman EL. Mediators of diabetic neuropathy: is hyperglycemia the only culprit? Curr Opin Endocrinol Diabetes Obes. 2017;24:103–11.PubMedPubMedCentral
11.
go back to reference Dyck PJ, Carter RE, Litchy WJ. Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy. Muscle Nerve. 2011;44:340–5.PubMedPubMedCentral Dyck PJ, Carter RE, Litchy WJ. Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy. Muscle Nerve. 2011;44:340–5.PubMedPubMedCentral
12.
13.
go back to reference Low PA, Zimmerman BR, Dyck PJ. Comparison of distal sympathetic with vagal function in diabetic neuropathy. Muscle Nerve. 1986;9:592–6.PubMed Low PA, Zimmerman BR, Dyck PJ. Comparison of distal sympathetic with vagal function in diabetic neuropathy. Muscle Nerve. 1986;9:592–6.PubMed
14.
go back to reference Landowski LM, Dyck PJ, Engelstad J, Taylor BV. Axonopathy in peripheral neuropathies: Mechanisms and therapeutic approaches for regeneration. J Chem Neuroanat. 2016;76:19–27.PubMed Landowski LM, Dyck PJ, Engelstad J, Taylor BV. Axonopathy in peripheral neuropathies: Mechanisms and therapeutic approaches for regeneration. J Chem Neuroanat. 2016;76:19–27.PubMed
15.
go back to reference Mizisin AP. Mechanisms of diabetic neuropathy: Schwann cells. Handb Clin Neurol. 2014;126:401–28.PubMed Mizisin AP. Mechanisms of diabetic neuropathy: Schwann cells. Handb Clin Neurol. 2014;126:401–28.PubMed
16.
go back to reference Goncalves NP, Vaegter CB, Andersen H, Ostergaard L, Calcutt NA, Jensen TS. Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nat Rev Neurol. 2017;13:135–47.PubMed Goncalves NP, Vaegter CB, Andersen H, Ostergaard L, Calcutt NA, Jensen TS. Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nat Rev Neurol. 2017;13:135–47.PubMed
17.
go back to reference Dyck PJ, Karnes JL, O’Brien P, Okazaki H, Lais A, Engelstad J. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol. 1986;19:440–9.PubMed Dyck PJ, Karnes JL, O’Brien P, Okazaki H, Lais A, Engelstad J. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol. 1986;19:440–9.PubMed
18.
go back to reference Nukada H. Ischemia and diabetic neuropathy. Handb Clin Neurol. 2014;126:469–87.PubMed Nukada H. Ischemia and diabetic neuropathy. Handb Clin Neurol. 2014;126:469–87.PubMed
19.
go back to reference Dyck PJ, Giannini C. Pathologic alterations in the diabetic neuropathies of humans: a review. J Neuropathol Exp Neurol. 1996;55:1181–93.PubMed Dyck PJ, Giannini C. Pathologic alterations in the diabetic neuropathies of humans: a review. J Neuropathol Exp Neurol. 1996;55:1181–93.PubMed
20.
go back to reference Zhou J, Zhou S. Inflammation: therapeutic targets for diabetic neuropathy. Mol Neurobiol. 2014;49:536–46.PubMed Zhou J, Zhou S. Inflammation: therapeutic targets for diabetic neuropathy. Mol Neurobiol. 2014;49:536–46.PubMed
21.
go back to reference Gwathmey KG, Burns TM, Collins MP, Dyck PJ. Vasculitic neuropathies. Lancet Neurol. 2014;13:67–82.PubMed Gwathmey KG, Burns TM, Collins MP, Dyck PJ. Vasculitic neuropathies. Lancet Neurol. 2014;13:67–82.PubMed
22.
go back to reference Giannini C, Dyck PJ. Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Ann Neurol. 1994;36:408–15.PubMed Giannini C, Dyck PJ. Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Ann Neurol. 1994;36:408–15.PubMed
23.
go back to reference Giannini C, Dyck PJ. Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol. 1995;37:498–504.PubMed Giannini C, Dyck PJ. Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol. 1995;37:498–504.PubMed
24.
go back to reference Korthals JK, Gieron MA, Dyck PJ. Intima of epineurial arterioles is increased in diabetic polyneuropathy. Neurology. 1988;38:1582–6.PubMed Korthals JK, Gieron MA, Dyck PJ. Intima of epineurial arterioles is increased in diabetic polyneuropathy. Neurology. 1988;38:1582–6.PubMed
25.
go back to reference Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain. 2008;131:1912–25.PubMedPubMedCentral Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain. 2008;131:1912–25.PubMedPubMedCentral
26.
go back to reference Low VA, Sandroni P, Fealey RD, Low PA. Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve. 2006;34:57–61.PubMed Low VA, Sandroni P, Fealey RD, Low PA. Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve. 2006;34:57–61.PubMed
27.
go back to reference Stewart JD, Low PA, Fealey RD. Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes. Muscle Nerve. 1992;15:661–5.PubMed Stewart JD, Low PA, Fealey RD. Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes. Muscle Nerve. 1992;15:661–5.PubMed
28.
go back to reference Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol. 1998;44:47–59.PubMed Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol. 1998;44:47–59.PubMed
29.
go back to reference Herrmann DN, Griffin JW, Hauer P, Cornblath DR, McArthur JC. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology. 1999;53:1634–40.PubMed Herrmann DN, Griffin JW, Hauer P, Cornblath DR, McArthur JC. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology. 1999;53:1634–40.PubMed
30.
go back to reference Terkelsen AJ, Karlsson P, Lauria G, Freeman R, Finnerup NB, Jensen TS. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. Lancet Neurol. 2017;16:934–44.PubMed Terkelsen AJ, Karlsson P, Lauria G, Freeman R, Finnerup NB, Jensen TS. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. Lancet Neurol. 2017;16:934–44.PubMed
31.
go back to reference McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol. 1998;55:1513–20.PubMed McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol. 1998;55:1513–20.PubMed
32.
go back to reference Provitera V, Gibbons CH, Wendelschafer-Crabb G, Donadio V, Vitale DF, Stancanelli A, et al. A multi-center, multinational age- and gender-adjusted normative dataset for immunofluorescent intraepidermal nerve fiber density at the distal leg. Eur J Neurol. 2016;23:333–8.PubMed Provitera V, Gibbons CH, Wendelschafer-Crabb G, Donadio V, Vitale DF, Stancanelli A, et al. A multi-center, multinational age- and gender-adjusted normative dataset for immunofluorescent intraepidermal nerve fiber density at the distal leg. Eur J Neurol. 2016;23:333–8.PubMed
33.
go back to reference Thaisetthawatkul P, Fernandes Filho JA, Herrmann DN. Contribution of QSART to the diagnosis of small fiber neuropathy. Muscle Nerve. 2013;48:883–8.PubMed Thaisetthawatkul P, Fernandes Filho JA, Herrmann DN. Contribution of QSART to the diagnosis of small fiber neuropathy. Muscle Nerve. 2013;48:883–8.PubMed
34.
go back to reference Thaisetthawatkul P, Fernandes Filho JA, Herrmann DN. Autonomic evaluation is independent of somatic evaluation for small fiber neuropathy. J Neurol Sci. 2014;344:51–4.PubMed Thaisetthawatkul P, Fernandes Filho JA, Herrmann DN. Autonomic evaluation is independent of somatic evaluation for small fiber neuropathy. J Neurol Sci. 2014;344:51–4.PubMed
35.
go back to reference Singer W, Spies JM, McArthur J, Low J, Griffin JW, Nickander KK, et al. Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies. Neurology. 2004;62:612–8.PubMed Singer W, Spies JM, McArthur J, Low J, Griffin JW, Nickander KK, et al. Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies. Neurology. 2004;62:612–8.PubMed
36.
go back to reference Schrezenmaier C, Singer W, Muenter Swift N, Sletten D, Tanabe J, Low PA. Adrenergic and vagal baroreflex sensitivity in autonomic failure. Arch Neurol. 2007;64:381–6.PubMed Schrezenmaier C, Singer W, Muenter Swift N, Sletten D, Tanabe J, Low PA. Adrenergic and vagal baroreflex sensitivity in autonomic failure. Arch Neurol. 2007;64:381–6.PubMed
37.
go back to reference Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T, et al. Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation. 1998;98:961–8.PubMed Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T, et al. Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation. 1998;98:961–8.PubMed
38.
go back to reference Stevens MJ, Raffel DM, Allman KC, Schwaiger M, Wieland DM. Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography. Metabolism. 1999;48:92–101.PubMed Stevens MJ, Raffel DM, Allman KC, Schwaiger M, Wieland DM. Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography. Metabolism. 1999;48:92–101.PubMed
39.
go back to reference Veglio M, Carpano-Maglioli P, Tonda L, Quadri R, Giannella R, Rosa C, et al. Autonomic neuropathy in non-insulin-dependent diabetic patients: correlation with age, sex, duration and metabolic control of diabetes. Diab Metab. 1990;16:200–6. Veglio M, Carpano-Maglioli P, Tonda L, Quadri R, Giannella R, Rosa C, et al. Autonomic neuropathy in non-insulin-dependent diabetic patients: correlation with age, sex, duration and metabolic control of diabetes. Diab Metab. 1990;16:200–6.
40.
41.
go back to reference Hilsted J, Parving HH, Christensen NJ, Benn J, Galbo H. Hemodynamics in diabetic orthostatic hypotension. J Clin Invest. 1981;68:1427–34.PubMedPubMedCentral Hilsted J, Parving HH, Christensen NJ, Benn J, Galbo H. Hemodynamics in diabetic orthostatic hypotension. J Clin Invest. 1981;68:1427–34.PubMedPubMedCentral
42.
go back to reference Low PA, Walsh JC, Huang CY, McLeod JG. The sympathetic nervous system in diabetic neuropathy. A clinical and pathological study. Brain. 1975;98:341–56.PubMed Low PA, Walsh JC, Huang CY, McLeod JG. The sympathetic nervous system in diabetic neuropathy. A clinical and pathological study. Brain. 1975;98:341–56.PubMed
43.
go back to reference Fujimura J, Camilleri M, Low PA, Novak V, Novak P, Opfer-Gehrking TL. Effect of perturbations and a meal on superior mesenteric artery flow in patients with orthostatic hypotension. J Auton Nerv Syst. 1997;67:15–23.PubMed Fujimura J, Camilleri M, Low PA, Novak V, Novak P, Opfer-Gehrking TL. Effect of perturbations and a meal on superior mesenteric artery flow in patients with orthostatic hypotension. J Auton Nerv Syst. 1997;67:15–23.PubMed
44.
go back to reference Palma J, Norcliffe LJ, Martinez J, Kaufmann H. Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension. Neurology. 2018;91:e1539–44.PubMedPubMedCentral Palma J, Norcliffe LJ, Martinez J, Kaufmann H. Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension. Neurology. 2018;91:e1539–44.PubMedPubMedCentral
45.
go back to reference Camilleri M, Chedid V, Ford AC, Haruma K, Horowitz M, Jones KL, et al. Gastroparesis. Nat Rev. 2018;4:41–58. Camilleri M, Chedid V, Ford AC, Haruma K, Horowitz M, Jones KL, et al. Gastroparesis. Nat Rev. 2018;4:41–58.
46.
go back to reference Bharucha AE, Batey-Schaefer B, Cleary PA, Murray JA, Cowie C, Lorenzi G, et al. Delayed gastric emptying is associated with early and long- term hyperglycemia in type 1 diabetes mellitus. Gastroenterology. 2015;149:330–9.PubMedPubMedCentral Bharucha AE, Batey-Schaefer B, Cleary PA, Murray JA, Cowie C, Lorenzi G, et al. Delayed gastric emptying is associated with early and long- term hyperglycemia in type 1 diabetes mellitus. Gastroenterology. 2015;149:330–9.PubMedPubMedCentral
47.
48.
go back to reference Low PA, Hilz M. Diabetic Autonomic Neuropathy. In: Low PA, Benarroch EE, editors. Clinical Autonomic Neuropathy. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 423–40. Low PA, Hilz M. Diabetic Autonomic Neuropathy. In: Low PA, Benarroch EE, editors. Clinical Autonomic Neuropathy. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 423–40.
49.
go back to reference Scarpello JH, Sladen GE. Diabetes and the gut. Gut. 1978;19:1153–62.PubMed Scarpello JH, Sladen GE. Diabetes and the gut. Gut. 1978;19:1153–62.PubMed
51.
go back to reference Scarpello JH, Hague RV, Cullen DR, Sladen GE. The 14C-glycocholate test in diabetic diarrhoea. Br Med J. 1976;2:673–5.PubMedPubMedCentral Scarpello JH, Hague RV, Cullen DR, Sladen GE. The 14C-glycocholate test in diabetic diarrhoea. Br Med J. 1976;2:673–5.PubMedPubMedCentral
52.
go back to reference Katz LA, Spiro HM. Gastrointestinal manifestations of diabetes. N Engl J Med. 1966;275:1350–61.PubMed Katz LA, Spiro HM. Gastrointestinal manifestations of diabetes. N Engl J Med. 1966;275:1350–61.PubMed
53.
go back to reference Battle WM, Snape WJ Jr, Alavi A, Cohen S, Braunstein S. Colonic dysfunction in diabetes mellitus. Gastroenterology. 1980;79:1217–21.PubMed Battle WM, Snape WJ Jr, Alavi A, Cohen S, Braunstein S. Colonic dysfunction in diabetes mellitus. Gastroenterology. 1980;79:1217–21.PubMed
54.
go back to reference Fealey RD, Low PA, Thomas JE. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc. 1989;64:617–28.PubMed Fealey RD, Low PA, Thomas JE. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc. 1989;64:617–28.PubMed
55.
go back to reference Dutsch M, Hilz MJ, Neundorfer B. Diabetic autonomic neuropathy. Fortschr Neurol Psychiatr. 2001;69:423–38.PubMed Dutsch M, Hilz MJ, Neundorfer B. Diabetic autonomic neuropathy. Fortschr Neurol Psychiatr. 2001;69:423–38.PubMed
56.
57.
go back to reference Frimodt-Moller C. Diabetic cystopathy. A clinical study of the frequency of bladder. Dan Med Bull. 1976;23:267–79. Frimodt-Moller C. Diabetic cystopathy. A clinical study of the frequency of bladder. Dan Med Bull. 1976;23:267–79.
58.
go back to reference Frimodt-Moller C. Diabetic cystopathy. A review of the urodynamic and clinical features of neurogenic bladder dysfunction in diabetes mellitus. Dan Med Bull. 1978;25:49–60. Frimodt-Moller C. Diabetic cystopathy. A review of the urodynamic and clinical features of neurogenic bladder dysfunction in diabetes mellitus. Dan Med Bull. 1978;25:49–60.
59.
go back to reference Beylot M, Marion D, Noel G. Ultrasonographic determination of residual urine in diabetic subjects: relationship to neuropathy and urinary tract infection. Diabetes Care. 1982;5:501–5.PubMed Beylot M, Marion D, Noel G. Ultrasonographic determination of residual urine in diabetic subjects: relationship to neuropathy and urinary tract infection. Diabetes Care. 1982;5:501–5.PubMed
60.
go back to reference Blaivas JG. The neurophysiology of micturition: a clinical study of 550 patients. J Urol. 1982;127:958–63.PubMed Blaivas JG. The neurophysiology of micturition: a clinical study of 550 patients. J Urol. 1982;127:958–63.PubMed
61.
go back to reference Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54–61.PubMed Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54–61.PubMed
62.
go back to reference Ellenberg M. Impotence in diabetes: the neurologic factor. Ann Intern Med. 1971;75:213–9.PubMed Ellenberg M. Impotence in diabetes: the neurologic factor. Ann Intern Med. 1971;75:213–9.PubMed
63.
go back to reference McCulloch DK, Young RJ, Prescott RJ, Campbell IW, Clarke BF. The natural history of impotence in diabetic men. Diabetologia. 1984;26:437–40.PubMed McCulloch DK, Young RJ, Prescott RJ, Campbell IW, Clarke BF. The natural history of impotence in diabetic men. Diabetologia. 1984;26:437–40.PubMed
64.
go back to reference Ellenberg M, Weber H. Retrograde ejaculation in diabetic neuropathy. Ann Intern Med. 1966;65:1237–46.PubMed Ellenberg M, Weber H. Retrograde ejaculation in diabetic neuropathy. Ann Intern Med. 1966;65:1237–46.PubMed
65.
go back to reference Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med. 1989;320:1025–30. Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med. 1989;320:1025–30.
66.
go back to reference Enzlin P, Mathieu C, Van Den Bruel A, Vanderschueren D, Demyttenaere K. Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes. Diabetes Care. 2003;26:409–14.PubMed Enzlin P, Mathieu C, Van Den Bruel A, Vanderschueren D, Demyttenaere K. Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes. Diabetes Care. 2003;26:409–14.PubMed
67.
go back to reference Enzlin P, Mathieu C, Van den Bruel A, Bosteels J, Vanderschueren D, Demyttenaere K. Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care. 2002;25:672–7.PubMed Enzlin P, Mathieu C, Van den Bruel A, Bosteels J, Vanderschueren D, Demyttenaere K. Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care. 2002;25:672–7.PubMed
68.
go back to reference Dutsch M, Marthol H, Michelson G, Neundorfer B, Hilz MJ. Pupillography refines the diagnosis of diabetic autonomic neuropathy. J Neurol Sci. 2004;222:75–81.PubMed Dutsch M, Marthol H, Michelson G, Neundorfer B, Hilz MJ. Pupillography refines the diagnosis of diabetic autonomic neuropathy. J Neurol Sci. 2004;222:75–81.PubMed
69.
go back to reference Martyn CN, Ewing DJ. Pupil cycle time—a simple way of measuring an autonomic reflex. J Neurol Neurosurg Psychiatry. 1986;49:771–4.PubMedPubMedCentral Martyn CN, Ewing DJ. Pupil cycle time—a simple way of measuring an autonomic reflex. J Neurol Neurosurg Psychiatry. 1986;49:771–4.PubMedPubMedCentral
70.
go back to reference Ewing DJ, Boland O, Neilson JM, Cho CG, Clarke BF. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia. 1991;34:182–5.PubMed Ewing DJ, Boland O, Neilson JM, Cho CG, Clarke BF. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia. 1991;34:182–5.PubMed
71.
go back to reference O’Brien IA, OHare JP, Lewin IG, Corrall RJ. The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: a controlled study based on heart rate variability. Q J Med. 1986;61:957–67. O’Brien IA, OHare JP, Lewin IG, Corrall RJ. The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: a controlled study based on heart rate variability. Q J Med. 1986;61:957–67.
72.
go back to reference Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003;26:1895–901.PubMed Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003;26:1895–901.PubMed
73.
go back to reference Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553–79.PubMed Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553–79.PubMed
74.
go back to reference Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care. 2006;29:334–9.PubMed Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care. 2006;29:334–9.PubMed
75.
go back to reference Jermendy G, Toth L, Voros P, Koltai MZ, Pogatsa G. QT interval in diabetic autonomic neuropathy. Diabet Med. 1990;7:750.PubMed Jermendy G, Toth L, Voros P, Koltai MZ, Pogatsa G. QT interval in diabetic autonomic neuropathy. Diabet Med. 1990;7:750.PubMed
77.
go back to reference Rajabally YA, Stettner M, Kieseier BC, Hartung HP, Malik RA. CIDP and other inflammatory neuropathies in diabetes—diagnosis and management. Nat Rev Neurol. 2017;13:599–611.PubMed Rajabally YA, Stettner M, Kieseier BC, Hartung HP, Malik RA. CIDP and other inflammatory neuropathies in diabetes—diagnosis and management. Nat Rev Neurol. 2017;13:599–611.PubMed
78.
go back to reference Bril V, Blanchette CM, Noone JM, Runken MC, Gelinas D, Russell JW. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy. J Diabetes Complications. 2016;30:1401–7.PubMedPubMedCentral Bril V, Blanchette CM, Noone JM, Runken MC, Gelinas D, Russell JW. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy. J Diabetes Complications. 2016;30:1401–7.PubMedPubMedCentral
79.
go back to reference Laughlin RS, Dyck PJ, Melton LJr, Leibson C, Ransom J, Dyck PJ. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurol India. 2009 73:39–45.PubMedPubMedCentral Laughlin RS, Dyck PJ, Melton LJr, Leibson C, Ransom J, Dyck PJ. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurol India. 2009 73:39–45.PubMedPubMedCentral
80.
go back to reference Latov N. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies. Nat Rev Neurol. 2014;10:435–46.PubMed Latov N. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies. Nat Rev Neurol. 2014;10:435–46.PubMed
81.
go back to reference Breiner A, Barnett Tapia C, Lovblom LE, Perkins BA, Katzberg HD, Bril V. Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes. Neurol Neuroimmunol NeuroInflamm. 2019; 6:e586.PubMed Breiner A, Barnett Tapia C, Lovblom LE, Perkins BA, Katzberg HD, Bril V. Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes. Neurol Neuroimmunol NeuroInflamm. 2019; 6:e586.PubMed
82.
go back to reference Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000;343:847–55.PubMed Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000;343:847–55.PubMed
84.
go back to reference Barohn RJ, Sahenk Z, Warmolts JR, Mendell JR. The Bruns–Garland syndrome (diabetic amyotrophy) revisited 100 years later. Arch Neurol. 1991;48:1130–5.PubMed Barohn RJ, Sahenk Z, Warmolts JR, Mendell JR. The Bruns–Garland syndrome (diabetic amyotrophy) revisited 100 years later. Arch Neurol. 1991;48:1130–5.PubMed
85.
go back to reference Coppack SW, Watkins PJ. The natural history of diabetic femoral neuropathy. Q J Med. 1991;79:307–13.PubMed Coppack SW, Watkins PJ. The natural history of diabetic femoral neuropathy. Q J Med. 1991;79:307–13.PubMed
86.
go back to reference Suarez GA, Giannini C, Bosch EP, Barohn RJ, Wodak J, Ebeling P, et al. Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesis. Neurology. 1996;46:559–61.PubMed Suarez GA, Giannini C, Bosch EP, Barohn RJ, Wodak J, Ebeling P, et al. Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesis. Neurology. 1996;46:559–61.PubMed
87.
go back to reference Massie R, Mauermann ML, Staff NP, Amrami KK, Mandrekar JN, Dyck PJ, et al. Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies. Brain. 2012;135:3074–88.PubMed Massie R, Mauermann ML, Staff NP, Amrami KK, Mandrekar JN, Dyck PJ, et al. Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies. Brain. 2012;135:3074–88.PubMed
88.
go back to reference Dyck PJ, Thaisetthawatkul P. Lumbosacral Plexopathy. CONTINUUM: Lifelong Learn Neurol. 2014;20:1343–58.PubMed Dyck PJ, Thaisetthawatkul P. Lumbosacral Plexopathy. CONTINUUM: Lifelong Learn Neurol. 2014;20:1343–58.PubMed
89.
go back to reference Pasnoor M, Dimachkie MM, Barohn RJ. Diabetic neuropathy part 2: proximal and asymmetric phenotypes. Neurol Clin. 2013;31:447–62.PubMedPubMedCentral Pasnoor M, Dimachkie MM, Barohn RJ. Diabetic neuropathy part 2: proximal and asymmetric phenotypes. Neurol Clin. 2013;31:447–62.PubMedPubMedCentral
90.
go back to reference Pascoe MK, Low PA, Windebank AJ, Litchy WJ. Subacute diabetic proximal neuropathy. Mayo Clin Proc. 1997;72:1123–32.PubMed Pascoe MK, Low PA, Windebank AJ, Litchy WJ. Subacute diabetic proximal neuropathy. Mayo Clin Proc. 1997;72:1123–32.PubMed
91.
go back to reference Subramony SH, Wilbourn AJ. Diabetic proximal neuropathy. Clinical and electromyographic studies. J Neurol Sci. 1982;53:293–304.PubMed Subramony SH, Wilbourn AJ. Diabetic proximal neuropathy. Clinical and electromyographic studies. J Neurol Sci. 1982;53:293–304.PubMed
92.
go back to reference Dyck PJ, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve. 2002;25:477–91.PubMed Dyck PJ, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve. 2002;25:477–91.PubMed
94.
go back to reference Ng PS, Dyck PJ, Laughlin RS, Thapa P, Pinto MV, Dyck PJB. Lumbosacral radiculoplexus neuropathy: incidence and the association with diabetes mellitus. Neurology. 2019;92:e1188–94.PubMedPubMedCentral Ng PS, Dyck PJ, Laughlin RS, Thapa P, Pinto MV, Dyck PJB. Lumbosacral radiculoplexus neuropathy: incidence and the association with diabetes mellitus. Neurology. 2019;92:e1188–94.PubMedPubMedCentral
95.
go back to reference Laughlin RS, Dyck PJ. Electrodiagnostic testing in lumbosacral plexopathies. Phys Med Rehabil Clin N Am. 2013;24:93–105.PubMed Laughlin RS, Dyck PJ. Electrodiagnostic testing in lumbosacral plexopathies. Phys Med Rehabil Clin N Am. 2013;24:93–105.PubMed
96.
go back to reference Dyck PJB, Norell JE, Dyck PJ. Methylprednisolone may improve lumbosacral radiculoplexus neuropathy. Can J Neurol Sci. 2001;28:224–7.PubMed Dyck PJB, Norell JE, Dyck PJ. Methylprednisolone may improve lumbosacral radiculoplexus neuropathy. Can J Neurol Sci. 2001;28:224–7.PubMed
97.
go back to reference Dyck PJ, Norell JE, Dyck PJ. Non-diabetic lumbosacral radiculoplexus neuropathy: natural history, outcome and comparison with the diabetic variety. Brain. 2001;124:1197–207.PubMed Dyck PJ, Norell JE, Dyck PJ. Non-diabetic lumbosacral radiculoplexus neuropathy: natural history, outcome and comparison with the diabetic variety. Brain. 2001;124:1197–207.PubMed
98.
go back to reference Caravati CM. Insulin neuritis. A case report. Va Med Mon. 1933;59:745–6. Caravati CM. Insulin neuritis. A case report. Va Med Mon. 1933;59:745–6.
99.
go back to reference Llewelyn JG, Thomas PK, Fonseca V, King RH, Dandona P. Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol. 1986;72:157–63.PubMed Llewelyn JG, Thomas PK, Fonseca V, King RH, Dandona P. Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol. 1986;72:157–63.PubMed
100.
go back to reference Tesfaye S, Malik R, Harris N, Jakubowski JJ, Mody C, Rennie IG, et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia. 1996;39:329–35.PubMed Tesfaye S, Malik R, Harris N, Jakubowski JJ, Mody C, Rennie IG, et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia. 1996;39:329–35.PubMed
101.
go back to reference Gibbons CH, Freeman R. Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol. 2010;67:534–41.PubMedPubMedCentral Gibbons CH, Freeman R. Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol. 2010;67:534–41.PubMedPubMedCentral
102.
go back to reference Gibbons CH, Freeman R. Clinical implications of delayed orthostatic hypotension: a 10-year follow-up study. Neurology. 2015;85:1362–7.PubMedPubMedCentral Gibbons CH, Freeman R. Clinical implications of delayed orthostatic hypotension: a 10-year follow-up study. Neurology. 2015;85:1362–7.PubMedPubMedCentral
103.
go back to reference Low PA, Singer W. Treatment-induced neuropathy of diabetes: an energy crisis? Brain. 2015;138:2–3.PubMed Low PA, Singer W. Treatment-induced neuropathy of diabetes: an energy crisis? Brain. 2015;138:2–3.PubMed
Metadata
Title
Spectrum of diabetic neuropathies
Authors
Hideyuki Sasaki
Nobutoshi Kawamura
Peter J. Dyck
P. James B. Dyck
Mikihiro Kihara
Phillip A. Low
Publication date
01-04-2020
Publisher
Springer Singapore
Published in
Diabetology International / Issue 2/2020
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-019-00424-7

Other articles of this Issue 2/2020

Diabetology International 2/2020 Go to the issue